Emergent BioSolutions Inc

NYSE:EBSUnited States

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.

Contact Information

Headquarters

300 Professional DrGAITHERSBURG, MD, United States 20879

Phone

240-631-3200

Fax

240-631-3203

Executives

Independent Chairman of the Board

Zsolt Harsanyi

President, Chief Executive Officer, Director

Joseph Papa

Chief Financial Officer, Executive Vice President, Treasurer

Richard Lindahl

Executive Vice President - Quality and Ethics and Compliance

Coleen Glessner

Senior Vice President - Products Business

Paul Williams